Federal · H.R. 1734 · 118th Congress
TRANQ Research Act
This bill requires the National Institute of Standards and Technology (NIST) to support research and other activities related to identifying xylazine (a compound used in veterinary medicine as a nonopioid tranquilizer), novel synthetic opioids, and other new psychoactive substances. In particular, NIST must support basic measurement science and research; near-real time spectrometry capabilities (i.e., a technique for rapidly identifying the chemical composition of a substance); strategies and voluntary best practices for handling, transporting, and analyzing such substances; and collaboration with other government agencies, institutions of higher education, and the private sector to enhance relevant narcotic and opioid detection and analysis capabilities.
First two sentences of the Congressional Research Service's summary · Congress.gov ↗
This bill requires the National Institute of Standards and Technology (NIST) to support research and other activities related to identifying xylazine (a compound used in veterinary medicine as a nonopioid tranquilizer), novel synthetic opioids, and other new psychoactive substances.
Passed the House on May 11, 2023. Waiting on the Senate.
Find your representatives to see how yours voted.
First two sentences of the Congressional Research Service's summary · Congress.gov ↗. A plain-words version comes later. Official page ↗
Your reps
Find your representatives to see how yours voted.
Latest final vote: Passed · U.S. House · May 11, 2023
Official record ↗Constitution
Not yet mapped. The parts of the Constitution this bill touches appear here once an analysis is written and checked.
Want an analysis of this bill? A full analysis maps every provision it touches.
All votes
U.S. House · May 11, 2023 · Final passage
On Motion to Suspend the Rules and Pass, as Amended · Passed
Official record ↗By party
| Party | Yes | No | Present | Not voting |
|---|---|---|---|---|
| Republican | 184 | 0 | 0 | 2 |
| Democratic | 172 | 0 | 0 | 5 |
| Democrat | 6 | 0 | 0 | 0 |
| Independent | 1 | 0 | 0 | 0 |
By state (48)
| State | Yes | No | Present | Not voting |
|---|---|---|---|---|
| AL | 6 | 0 | 0 | 0 |
| AR | 3 | 0 | 0 | 1 |
| AZ | 7 | 0 | 0 | 0 |
| CA | 52 | 0 | 0 | 0 |
| CO | 4 | 0 | 0 | 1 |
| CT | 5 | 0 | 0 | 0 |
| DE | 1 | 0 | 0 | 0 |
| FL | 23 | 0 | 0 | 1 |
| GA | 10 | 0 | 0 | 1 |
| HI | 2 | 0 | 0 | 0 |
| IA | 4 | 0 | 0 | 0 |
| ID | 2 | 0 | 0 | 0 |
| IL | 16 | 0 | 0 | 1 |
| IN | 7 | 0 | 0 | 0 |
| KS | 3 | 0 | 0 | 0 |
| KY | 6 | 0 | 0 | 0 |
| LA | 5 | 0 | 0 | 0 |
| MA | 9 | 0 | 0 | 0 |
| MD | 5 | 0 | 0 | 0 |
| ME | 2 | 0 | 0 | 0 |
| MI | 11 | 0 | 0 | 1 |
| MN | 7 | 0 | 0 | 0 |
| MO | 6 | 0 | 0 | 0 |
| MS | 4 | 0 | 0 | 0 |
| MT | 1 | 0 | 0 | 0 |
| NC | 9 | 0 | 0 | 0 |
| NE | 3 | 0 | 0 | 0 |
| NH | 1 | 0 | 0 | 0 |
| NJ | 9 | 0 | 0 | 0 |
| NM | 3 | 0 | 0 | 0 |
| NV | 4 | 0 | 0 | 0 |
| NY | 20 | 0 | 0 | 0 |
| OH | 13 | 0 | 0 | 0 |
| OK | 5 | 0 | 0 | 0 |
| OR | 4 | 0 | 0 | 0 |
| PA | 14 | 0 | 0 | 1 |
| RI | 1 | 0 | 0 | 0 |
| SC | 6 | 0 | 0 | 0 |
| SD | 1 | 0 | 0 | 0 |
| TN | 8 | 0 | 0 | 0 |
| TX | 33 | 0 | 0 | 0 |
| UT | 3 | 0 | 0 | 0 |
| VA | 7 | 0 | 0 | 0 |
| VT | 1 | 0 | 0 | 0 |
| WA | 8 | 0 | 0 | 0 |
| WI | 7 | 0 | 0 | 0 |
| WV | 1 | 0 | 0 | 0 |
| WY | 1 | 0 | 0 | 0 |
The breakdown counts the 370 members whose positions are loaded; the totals above are the official record's.
Party is as each member's record lists it. Counts are of recorded positions, nothing more.
Every member's vote
370 members, by last name.
From the official record of each vote. A member who left office keeps their recorded position; their page shows the years they served.
Money
Lobbying reports for this bill haven't been searched yet. They're searched for every bill with a final-passage vote.
History
- May 11, 2023U.S. House: On Motion to Suspend the Rules and Pass, as Amended · Passed ↗
Recorded votes on this bill and the final action, as their sources record them. Committee and other steps without a recorded vote aren't listed; the official page has every action.
Final action
Not checked yet. The President's action on a bill appears here after the data sync looks it up.
From Congress.gov's record of the bill's actions.
Full text
Official summary (Congressional Research Service)
Testing, Rapid Analysis, and Narcotic Quality Research Act of 2023 or the TRANQ Research Act of 2023 This bill requires the National Institute of Standards and Technology (NIST) to support research and other activities related to identifying xylazine (a compound used in veterinary medicine as a nonopioid tranquilizer), novel synthetic opioids, and other new psychoactive substances. In particular, NIST must support basic measurement science and research; near-real time spectrometry capabilities (i.e., a technique for rapidly identifying the chemical composition of a substance); strategies and voluntary best practices for handling, transporting, and analyzing such substances; and collaboration with other government agencies, institutions of higher education, and the private sector to enhance relevant narcotic and opioid detection and analysis capabilities. Additionally, the Government Accountability Office must conduct a study on the capabilities of the federal government to detect, identify, and otherwise respond to threats of new psychoactive substances, such as xylazine.
Source ↗